Suppr超能文献

中药及其活性成分使癌细胞对 TRAIL 诱导的细胞凋亡敏感。

Traditional Chinese medicines and their active ingredients sensitize cancer cells to TRAIL-induced apoptosis.

机构信息

Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.

Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.

出版信息

J Zhejiang Univ Sci B. 2021 Mar 15;22(3):190-203. doi: 10.1631/jzus.B2000497.

Abstract

The rapidly developing resistance of cancers to chemotherapy agents and the severe cytotoxicity of such agents to normal cells are major stumbling blocks in current cancer treatments. Most current chemotherapy agents have significant cytotoxicity, which leads to devastating adverse effects and results in a substandard quality of life, including increased daily morbidity and premature mortality. The death receptor of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can sidestep p53-dependent pathways to induce tumor cell apoptosis without damaging most normal cells. However, various cancer cells can develop resistance to TRAIL-induced apoptosis via different pathways. Therefore, it is critical to find an efficient TRAIL sensitizer to reverse the resistance of tumor cells to TRAIL, and to reinforce TRAIL's ability to induce tumor cell apoptosis. In recent years, traditional Chinese medicines and their active ingredients have shown great potential to trigger apoptotic cell death in TRAIL-resistant cancer cell lines. This review aims to collate information about Chinese medicines that can effectively reverse the resistance of tumor cells to TRAIL and enhance TRAIL's ability to induce apoptosis. We explore the therapeutic potential of TRAIL and provide new ideas for the development of TRAIL therapy and the generation of new anti-cancer drugs for human cancer treatment. This study involved an extensive review of studies obtained from literature searches of electronic databases such as Google Scholar and PubMed. "TRAIL sensitize" and "Chinese medicine" were the search keywords. We then isolated newly published studies on the mechanisms of TRAIL-induced apoptosis. The name of each plant was validated using certified databases such as The Plant List. This study indicates that TRAIL can be combined with different Chinese medicine components through intrinsic or extrinsic pathways to promote cancer cell apoptosis. It also demonstrates that the active ingredients of traditional Chinese medicines enhance the sensitivity of cancer cells to TRAIL-mediated apoptosis. This provides useful information regarding traditional Chinese medicine treatment, the development of TRAIL-based therapies, and the treatment of cancer.

摘要

癌症对化疗药物的快速耐药性和这些药物对正常细胞的严重细胞毒性是当前癌症治疗的主要障碍。大多数当前的化疗药物具有显著的细胞毒性,这导致了破坏性的不良反应,并导致生活质量下降,包括日常发病率增加和过早死亡。肿瘤坏死因子相关凋亡诱导配体(TRAIL)的死亡受体可以绕过 p53 依赖性途径诱导肿瘤细胞凋亡,而不会损伤大多数正常细胞。然而,各种癌细胞可以通过不同的途径对 TRAIL 诱导的细胞凋亡产生耐药性。因此,找到有效的 TRAIL 敏化剂来逆转肿瘤细胞对 TRAIL 的耐药性,并增强 TRAIL 诱导肿瘤细胞凋亡的能力是至关重要的。近年来,中药及其活性成分在触发 TRAIL 耐药性肿瘤细胞系的凋亡细胞死亡方面显示出巨大的潜力。本综述旨在整理有关中药有效逆转肿瘤细胞对 TRAIL 的耐药性并增强 TRAIL 诱导凋亡能力的信息。我们探讨了 TRAIL 的治疗潜力,并为 TRAIL 治疗的发展和用于人类癌症治疗的新型抗癌药物的产生提供了新的思路。本研究通过对 Google Scholar 和 PubMed 等电子数据库的文献检索,广泛查阅了相关研究。“TRAIL 敏化”和“中药”是搜索关键词。然后,我们分离了关于 TRAIL 诱导凋亡机制的新发表研究。每种植物的名称都使用 The Plant List 等经过认证的数据库进行了验证。本研究表明,TRAIL 可以通过内在或外在途径与不同的中药成分结合,促进癌细胞凋亡。它还表明,中药的活性成分增强了癌细胞对 TRAIL 介导的凋亡的敏感性。这为中药治疗、TRAIL 为基础的治疗方法的开发以及癌症的治疗提供了有用的信息。

相似文献

2
TRIAL-based combination therapies in cancers.基于试验的癌症联合疗法。
Int Immunopharmacol. 2024 Sep 10;138:112570. doi: 10.1016/j.intimp.2024.112570. Epub 2024 Jul 6.
4
TRAIL as a target in anti-cancer therapy.肿瘤坏死因子相关凋亡诱导配体作为抗癌治疗的靶点。
Cancer Lett. 2009 Nov 18;285(1):1-5. doi: 10.1016/j.canlet.2009.02.029. Epub 2009 Mar 18.

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验